Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 6276 - 6300 of 8154 in total
E1v1.11 is an antisense oligonucleotide targeting the SMN2 gene which is under investigation for the treatment of spinal muscular atrophy (SMA).
Investigational
Matched Description: … antisense oligonucleotide targeting the _SMN2_ gene which is under investigation for the treatment of
Alintegimod is under investigation in clinical trial NCT06362369 (A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy).
Investigational
Matched Description: … Alintegimod is under investigation in clinical trial NCT06362369 (A Study of Oral 7HP349 (Alintegimod …
Orforglipron is under investigation in clinical trial NCT06010004 (A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes).
Investigational
Matched Description: … Orforglipron is under investigation in clinical trial NCT06010004 (A Long-term Safety Study of Orforglipron …
Stem cells obtained from amniotic fluid, the umbilical cord (UC), and placenta are gaining in popularity. Stem cells from the umbilical cord offer several advantages, including: non-invasive collection procedures, more hearty and steady growth than bone-marrow derived stem cells (they can maintain a steady doubling time (DT) over up to...
Investigational
Matched Description: … of extracted MSCs. ... The cord lining of the UC is generally isolated with the explant method -- resulting in two kinds of ... Currently many companies are creating their own version of these stem cells, one of which is by Aspire …
Surotomycin has been used in trials studying the treatment of Diarrhea and Clostridium Difficile Infection. It is a benzenebutanoic acid derivative patented by Cubist Pharmaceuticals, Inc. as antibacterial agents for the treatment of Gram-positive infections. Surotomycin has a fourfold greater in vitro potency than vancomycin against C. Difficile and other...
Investigational
Matched Description: … Surotomycin has been used in trials studying the treatment of Diarrhea and Clostridium Difficile Infection ... acid derivative patented by Cubist Pharmaceuticals, Inc. as antibacterial agents for the treatment of ... Difficile and other Gram-positive bacteria with minimal impact on the Gram-negative organisms of the …
Tengonermin, also known as NGR-hTNF, is a vascular-targeting drug. It is a recombinant protein and peptide-targeted agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. This drug works by modifying the tumor microenvironment and increasing intratumoral chemotherapy penetration and T-cell infiltration. NGR-hTNF specifically targets angiogenic...
Investigational
Matched Description: … of NGR-hTNF to tumor vessels and the increase in its antiangiogenic activity. ... [A233265] It is a recombinant protein and peptide-targeted agent consisting of the human Tumour Necrosis ... [A233270] A study also demonstrated that binding of the NGR-motif to CD13 determined both the homing …
Norvaline is an isomer of the more common amino acid valine.
Experimental
Matched Description: … Norvaline is an isomer of the more common amino acid valine. …
BMS-690514 has been investigated for the treatment of Breast Cancer.
Investigational
Matched Description: … BMS-690514 has been investigated for the treatment of Breast Cancer. …
E6201 has been investigated for the treatment of Chronic Plaque Psoriasis.
Investigational
Matched Description: … E6201 has been investigated for the treatment of Chronic Plaque Psoriasis. …
Carnosine has been investigated for the treatment of Gulf War Illness.
Investigational
Matched Description: … Carnosine has been investigated for the treatment of Gulf War Illness. …
Fedovapagon has been used in trials studying the treatment of Nocturia.
Investigational
Matched Description: … Fedovapagon has been used in trials studying the treatment of Nocturia. …
Arhalofenate has been investigated for the treatment of Gout and Hyperuricemia.
Investigational
Matched Description: … Arhalofenate has been investigated for the treatment of Gout and Hyperuricemia. …
Tegobuvir has been investigated for the treatment of Hepatitis C, Chronic.
Investigational
Matched Description: … Tegobuvir has been investigated for the treatment of Hepatitis C, Chronic. …
Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma.
Investigational
Matched Description: … Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma. …
Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute.
Investigational
Matched Description: … Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute. …
Vanutide cridificar has been investigated for the treatment of Alzheimer Disease.
Investigational
Matched Description: … Vanutide cridificar has been investigated for the treatment of Alzheimer Disease. …
Cordycepin has been used in trials studying the treatment of Leukemia.
Investigational
Matched Description: … Cordycepin has been used in trials studying the treatment of Leukemia. …
Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
Investigational
Matched Description: … Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome. …
Zicronapine has been used in trials studying the treatment of Schizophrenia.
Investigational
Matched Description: … Zicronapine has been used in trials studying the treatment of Schizophrenia. …
Defactinib has been investigated for the treatment of Malignant Pleural Mesothelioma.
Investigational
Matched Description: … Defactinib has been investigated for the treatment of Malignant Pleural Mesothelioma. …
Anrukinzumab has been used in trials studying the diagnostic of Asthma.
Investigational
Matched Description: … Anrukinzumab has been used in trials studying the diagnostic of Asthma. …
Tavilermide has been investigated for the treatment of Dry Eye Syndromes.
Investigational
Matched Description: … Tavilermide has been investigated for the treatment of Dry Eye Syndromes. …
Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.
Investigational
Matched Description: … Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer. …
PF-00446687 has been investigated for the treatment of Erectile Dysfunction.
Investigational
Matched Description: … PF-00446687 has been investigated for the treatment of Erectile Dysfunction. …
Intetumumab has been used in trials studying the treatment of Melanoma.
Investigational
Matched Description: … Intetumumab has been used in trials studying the treatment of Melanoma. …
Displaying drugs 6276 - 6300 of 8154 in total